Premium
An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non‐inflammatory tinea capitis
Author(s) -
HAROON T.S.,
HUSSAIN I.,
MAHMOOD A.,
NAGI A.H.,
AHMAD I.,
ZAHID M.
Publication year - 1992
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1992.tb00010.x
Subject(s) - medicine , terbinafine , family medicine , dermatology , antifungal , itraconazole
Summary Ten patients with dry non‐inflammatory tinea capitis were evaluated in a pilot study which ran from September 1989 to February 1990. Each patient was given oral terbinafine for 6 weeks; each was followed up 2 weeks later. Eight (80%) were completely cured, one (10%) was mycologically cured and showed minimal signs and symptoms, and another (10%) showed improvement (negative mycology, but persistent clinical signs and symptoms). No topical or systemic side‐effects were noted. Terbinafine appears to be an effective and safe antifungal agent in the treatment of non‐inflammatory tinea capitis.